2530 (2530) Fair Value & Analysis

Consumer Defensive · Market cap HK$750M

2 2530 2530 · HK

PriceHK$0.7500

Fair ValueHK$0.3400

Upside-54.7%

Quality62/100

Watch 2530 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.3400 – HK$0.3400

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price +0.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.4939 – HK$0.7900 · the HK$0.7500 price screens above the HK$0.3400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2530 (2530) currently trades at HK$0.7500, while our model-based Fair Value estimate is HK$0.3400 — implying the stock looks roughly 54.7% overvalued today. We read business quality at 62/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 2530 generated revenue of HK$189M at a net margin of 2.9%. Revenue declined 26.8% year over year. It earns a return on equity of 1.3%. The balance sheet holds a net cash position of HK$398M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$189M

Revenue growth (YoY) -26.8%

Net margin 2.9%

Return on equity 1.3%

Free cash flow HK$46.7M FY2025

P/E ratio 75.0

More key figures

Operating margin 7.8%

Dividend yield 3.3%

EPS growth (YoY) -91.5%

Net cash HK$398M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2530 reported revenue of HK$184M in FY2025 versus HK$338M in FY2021, a compound −14.0%/yr. Reported net income was HK$5.4M in FY2025, compounding −54.0%/yr from FY2021.

Revenue −14.0%/yr

FY21 HK$338M

FY22 HK$367M

FY23 HK$427M

FY24 HK$277M

FY25 HK$184M

Net income −54.0%/yr

FY21 HK$120M

FY22 HK$87.5M

FY23 HK$159M

FY24 HK$74.9M

FY25 HK$5.4M

Is 2530 fairly valued? → Check now

Similar stocks

6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 79.73	CHF 55.79	-30%
Foshan Haitian Flavouring and Food Company 603288	¥34.03	¥23.66	-30%
Nestlé India Limited NESTLEIND	₹1,386	₹278.10	-80%
3288 3288	HK$30.26	HK$27.44	-9%
Grupo Bimbo, S.A. BIMBOA	57.10 MXN	45.03 MXN	-21%
Uni-President Enterprises Corp 1216	73.80 TWD	61.57 TWD	-17%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2530 (2530) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3400 versus a price of HK$0.7500 — about −55% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 2530?

Our model-based fair value for 2530 is HK$0.3400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.7500.

What is the quality score of 2530?

2530 has a Quality Score of 62/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2530 (2530)?

2530 reported trailing-twelve-month revenue of about HK$189M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2530?

The net profit margin of 2530 is about 2.9%, meaning it keeps roughly 2.9% of revenue as net income. Based on the latest reported figures.

Does 2530 pay a dividend?

2530 currently shows a dividend yield of about 3.29% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.